PRODRUGS OF FLUORINATED MEVALONATES TO INHIBIT THE MEVALONATE PATHWAY OF STREPTOCOCCUS PNEUMONIAE

Title:

PRODRUGS OF FLUORINATED MEVALONATES TO INHIBIT THE MEVALONATE PATHWAY OF STREPTOCOCCUS PNEUMONIAE

Document Type and Number:

WIPO Patent Application WO/2013/130792

Kind Code:

A3

Abstract:

Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.

Inventors:

SILVERMAN RICHARD B (US)
WATANABE MIZUKI (JP)
KANG SOOSUNG (US)

Application Number:

PCT/US2013/028298

Publication Date:

October 24, 2013

Filing Date:

February 28, 2013

Export Citation:

Assignee:

UNIV NORTHWESTERN (US)
SILVERMAN RICHARD B (US)
WATANABE MIZUKI (JP)
KANG SOOSUNG (US)

International Classes:

C07D319/04; C07D309/30

Domestic Patent References:

WO2008108834A2	2008-09-12
WO2005053681A2	2005-06-16

Foreign References:

EP1555021A1

2005-07-20

Attorney, Agent or Firm:

DEKRUIF, Rodney, D. et al. (1000 N. Water StreetSuite 170, Milwaukee WI, US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: COMPOSITIONS, KITS, AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCE...

Next Patent: MULTI-USER PARALLEL CHANNEL ACCESS IN WLAN SYSTEMS